A review of research on directtoconsumer advertising of prescription drugs:Directions for future research

International Journal of Pharmaceutical and Healthcare Marketing

Volumn 7, Issue 3, 2013, Pages 226-243

  Mukherjee, Avinandan ^a   Limbu, Yam ^a   Wanasika, Isaac ^b  

^a MONTCLAIR STATE UNIVERSITY   (United States)

^b UNIVERSITY OF NORTHERN COLORADO   (United States)

Author keywords

Advertising effectiveness; Direct to consumer advertising; Pharmaceutical products; Prescription drugs; Research themes

Indexed keywords

EID: 84881582539     PISSN: 17506123     EISSN: None     Source Type: Journal    
DOI: 10.1108/IJPHM-07-2013-0037     Document Type: Article

References (53)

1. Amaldoss, W. and He, C. (2009), “Direct-to-consumer advertising of prescription drugs: a strategic analysis”, Marketing Science, Vol. 28 No. 3, pp. 472-487.
2. Bradley, L.R. and Zito, J.M. (1997), “Direct-to-consumer prescription drug advertising”, Medical Care, Vol. 35 No. 1, pp. 86-92.
3. Calfee, J.E. (2002), “Public policy issues in direct-to-consumer advertising of prescription drugs”, Journal of Public Policy & Marketing, Vol. 21 No. 2, pp. 174-193.
4. Capella, M.L., Taylor, C.R., Campbell, R.C. and Longwell, L.S. (2009), “Do pharmaceutical marketing activities raise prices? Evidence from five major therapeutic classes”, Journal of Public Policy & Marketing, Vol. 28 No. 2, pp. 146-161.
5. Coney, S. (2002), “Direct-to-consumer advertising of prescription pharmaceuticals: a consumer perspective from New Zealand”, Journal of Public Policy & Marketing, Vol. 21 No. 2, pp. 213-223.
6. Davis, J.J. (2000), “Riskier than we think? The relationship between risk statement completeness and perceptions of direct to consumer advertised prescription drugs”, Journal of Health Communication, Vol. 5 No. 4, pp. 349-369.
7. Davis, J.J. and Meader, A. (2009), “Beyond content analysis: assessing fair balance in DTC pharmaceutical advertising”, Journal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing, Vol. 9 No. 1, pp. 57-66.
8. Deshpande, A., Menon, A., Perri, M. III and Zinkhan, G. (2004), “Direct-to-consumer advertising and its utility in health care decision making: a consumer perspective”, Journal of Health Communication, Vol. 9 No. 6, pp. 499-513.
9. Diehl, S., Mueller, B. and Terlutter, R. (2008), “Consumer responses towards non-prescription and prescription drug advertising in the US and Germany: they don't really like it, but they do believe it”, International Journal of Advertising, Vol. 27 No. 1, pp. 99-131.
10. Donohue, J.M., Cevasco, M. and Rosenthal, M.B. (2007), “A decade of direct-to-consumer advertising of prescription drugs”, New England Journal of Medicine, Vol. 357 No. 7, pp. 673-681.
11. Farris, P.W. and Wilkie, W.L. (2005), “Marketing scholars' roles in the policy arena: an opportunity for discourse on direct-to-consumer advertising”, Journal of Public Policy & Marketing, Vol. 24 No. 1, pp. 3-6.
12. Frosch, D.L., Grande, D., Tarn, D.M. and Kravitz, R.L. (2010), “A decade of controversy: balancing policy with evidence in the regulation of prescription drug advertising”, Journal Information, Vol. 100 No. 1, pp. 24-32.
13. Frosch, D.L., Krueger, P.M., Hornik, R.C., Cronholm, P.F. and Barg, F.K. (2007), “Creating demand for prescription drugs: a content analysis of television direct-to-consumer advertising”, Annals of Family Medicine, Vol. 5 No. 1, pp. 6-13.
14. Gellad, Z.F. and Lyles, K.W. (2007), “Direct-to-consumer advertising of pharmaceuticals”, The American Journal of Medicine, Vol. 120 No. 6, pp. 475-480.
15. Gönül, F.F., Carter, F. and Wind, J. (2000), “What kind of patients and physicians value direct-to-consumer advertising of prescription drugs”, Health Care Management Science, Vol. 3 No. 3, pp. 215-226.
16. Handlin, A., Mosca, J.B., Forgione, D.A. and Pitta, D. (2003), “DTC pharmaceutical advertising: the debate's not over”, Journal of Consumer Marketing, Vol. 20 No. 3, pp. 227-237.
17. Harker, M. and Harker, D. (2007), “Direct-to-consumer advertising of prescription medicines: a systematic review of the evidence from the perspective of the consumer”, Journal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing, Vol. 7 No. 1, pp. 45-54.
18. Herzenstein, M., Misra, S. and Posavac, S.S. (2004), “How consumers' attitudes toward direct-to-consumer advertising of prescription drugs influence ad effectiveness, and consumer and physician behavior”, Marketing Letter, Vol. 15 No. 4, pp. 201-212.
19. Hoek, J., Gendall, P. and Feetham, P. (2001), “Could less be more? An analysis of direct to consumer advertising of prescription medicines”, Marketing Bulletin, Vol. 12, pp. 1-15.
20. Holmer, A.F. (1999), “Direct-to-consumer prescription drug advertising builds bridges between patients and physicians”, The Journal of The American Medical Association, Vol. 281 No. 4, pp. 380-382.
21. Huh, J. and Langteau, R. (2007), “Presumed influence of direct-to-consumer (DTC) prescription drug advertising on patients: the physician's perspective”, Journal of Advertising, Vol. 36 No. 3, pp. 151-172.
22. Huh, J., DeLorme, D.E. and Reid, L.N. (2004), “Media credibility and informativeness of direct-to-consumer prescription drug advertising”, Health Marketing Quarterly, Vol. 21 No. 3, pp. 27-61.
23. Huh, J. and Becker, L.B. (2005), “Direct-to-consumer prescription drug advertising: understanding its consequences”, International Journal of Advertising, Vol. 24 No. 4, p. 441.
24. Kalyanaram, G.K. (2009), “The endogenous modeling of the effect of direct-to-consumer advertising in prescription drugs”, International Journal of Pharmaceutical and Healthcare Marketing, Vol. 3 No. 2, pp. 137-148.
25. Khanfar, N., Loudon, D. and Sircar-Ramsewak, F. (2008), “FDA direct-to-consumer advertising for prescription drugs: what are consumer preferences and response tendencies?”, Health Marketing Quarterly, Vol. 24 Nos 1/2, pp. 77-91.
26. Khanfar, N., Polen, H.H. and Clauson, K.A. (2009), “Influence on consumer behavior: the impact of direct-to-consumer advertising on medication requests for gastroesophageal reflux disease and social anxiety disorder”, Journal of Health Communication, Vol. 14 No. 5, pp. 451-460.
27. Kim, K. and Park, J.S. (2010), “Message framing and the effectiveness of DTC advertising: the moderating role of subjective product knowledge”, Journal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing, Vol. 10 No. 2, pp. 165-176.
28. Kopp, S.W. and Sheffet, M.J. (1997), “The effect of direct-to-consumer advertising of prescription drugs on retail gross margins: empirical evidence and public policy implications”, Journal of Public Policy & Marketing, Vol. 16 No. 2, pp. 270-276.
29. Lee, A.L. (2009), “Changing effects of direct-to-consumer broadcast drug advertising information sources on prescription drug requests”, Health Communication, Vol. 24 No. 4, pp. 361-376.
30. Lee, A.L. (2010), “Who are the opinion leaders? The physicians, pharmacists, patients, and direct-to-consumer prescription drug advertising”, Journal of Health Communication, Vol. 15 No. 6, pp. 629-655.
31. Lee, B., Salmon, C.T. and Paek, H.J. (2007), “The effects of information sources on consumer reactions to direct-to-consumer (DTC) prescription drug advertising: a consumer socialization approach”, Journal of Advertising, Vol. 36 No. 1, pp. 107-119.
32. Limbu, Y.B. and Torres, I.M. (2009), “The effects of involvement and ad type on attitudes toward direct-to-consumer advertising of prescription drugs”, Journal of Health and Human Services Administration, Vol. 32 No. 1, pp. 107-138.
33. Limbu, Y.B., Huhmann, B.A. and Peterson, R.T. (2012), “An examination of humor and endorser effects on consumers' responses to direct-to-consumer advertising: the moderating role of product involvement”, International Journal of Pharmaceutical and Healthcare Marketing, Vol. 6 No. 1, pp. 23-38.
34. Lipsky, M.S. and Taylor, C.A. (1997), “The opinions and experiences of family physicians regarding direct-to-consumer advertising”, The Journal of Family Practice, Vol. 45 No. 6, pp. 495-499.
35. Macias, W., Pashupati, K. and Lewis, L.S. (2007), “A wonderful life or diarrhea and dry mouth? Policy issues of direct-to-consumer drug advertising on television”, Health Communication, Vol. 22 No. 3, pp. 241-252.
36. Mackert, M. and Love, B. (2011), “Educational content and health literacy issues in direct-to-consumer advertising of pharmaceuticals”, Health Marketing Quarterly, Vol. 28 No. 3, pp. 205-218.
37. Main, K.J., Argo, J.J. and Huhmann, B.A. (2004), “Pharmaceutical advertising in the USA: information or influence?”, International Journal of Advertising, Vol. 23 No. 1, pp. 119-142.
38. Menon, A.M., Deshpande, A.D., Perri, M. III and Zinkhan, G.M. (2003a), “Consumers' attention to the brief summary in print direct-to-consumer advertisements: perceived usefulness in patient-physician discussions”, Journal of Public Policy & Marketing, Vol. 22 No. 2, pp. 181-191.
39. Menon, A.M., Deshpande, A.D., Perri, M. III and Zinkhan, G. (2003b), “Trust in online prescription drug information among Internet users: the impact on information search behavior after exposure to direct-to-consumer advertising”, Health Marketing Quarterly, Vol. 20 No. 1, pp. 17-35.
40. Narayanan, S., Desiraju, R. and Chintagunta, P.K. (2004), “Return on investment implications for pharmaceutical promotional expenditures: the role of marketing-mix interactions”, Journal of Marketing, Vol. 68 No. 4, pp. 90-105.
41. Park, J.S. and Grow, J.M. (2010), “Symptom information in direct-to-consumer antidepressant advertising and college students' perception of the lifetime risk of depression”, Journal of Medical Marketing, Vol. 10 No. 2, pp. 1-16.
42. Parker, R.S. and Pettijohn, C.E. (2003), “Ethical considerations in the use of direct-to-consumer advertising and pharmaceutical promotions: the impact on pharmaceutical sales and physicians”, Journal of Business Ethics, Vol. 48 No. 3, pp. 279-290.
43. Peyrot, M. and Alperstein, N.M. (1993), “Consumer awareness of prescription drug advertising”, Journal of Advertising Research, Vol. 33 No. 4, pp. 50-56.
44. Peyrot, M., Alperstein, N.M., Van Doren, D. and Poli, L.G. (1998), “Direct-to-consumer ads can influence behavior. Advertising increases consumer knowledge and prescription drug requests”, Marketing Health Services, Vol. 18 No. 2, p. 26.
45. Roth, M.S. (2003), “Media and message effects on DTC prescription drug print advertising awareness”, Journal of Advertising Research, Vol. 43 No. 2, pp. 180-193.
46. Royne, M.B. and Myers, S.D. (2008), “Recognizing consumer issues in DTC pharmaceutical advertising”, Journal of Consumer Affairs, Vol. 42 No. 1, pp. 60-80.
47. Sen, K.C. (2011), “An empirical investigation of the variations in direct-to-consumer prescription drug advertising”, International Journal of Pharmaceutical and Healthcare Marketing, Vol. 5 No. 4, pp. 248-261.
48. Singh, T. and Smith, D. (2005), “Direct-to-consumer prescription drug advertising: a study of consumer attitudes and behavioral intentions”, Journal of Consumer Marketing, Vol. 22 No. 7, pp. 369-378.
49. Sumpradit, N., Fors, S.W. and McCormick, L. (2002), “Consumers' attitudes and behavior toward prescription drug advertising”, American Journal of Health Behavior, Vol. 26 No. 1, pp. 68-75.
50. Weissman, J.S., Blumenthal, D., Silk, A.J., Zapert, K., Newman, M. and Leitman, R. (2003), “Consumers' reports on the health effects of direct-to-consumer drug advertising”, Health Affairs, Vol. 22 No. 3, pp. 82-95.
51. Weissman, J.S., Blumenthal, D., Silk, A.J., Newman, M., Zapert, K., Leitman, R. and Feibelmann, S. (2004), “Physicians report on patient encounters involving direct-to-consumer advertising”, Health Affairs, Vol. 23 No. 3, pp. 219-233.
52. Wilkes, M.S., Bell, R.A. and Kravitz, R.L. (2000), “Direct-to-consumer prescription drug advertising: trends, impact, and implications”, Health Affairs, Vol. 19 No. 2, pp. 110-128.
53. Wilson, R.T. and Till, B.D. (2007), “Direct-to-consumer pharmaceutical advertising: building and testing a model for advertising effectiveness”, Journal of Advertising Research, Vol. 47 No. 3, p. 270.